Infectious Diseases, Institute of Biomedicine,
Sahlgrenska Academy, University of Gothenburg
Antiretroviral therapy (ART) has had a major impact in reducing HIV-1 related disease in the CNS, including HIV-associated dementia, but milder forms of neurocognitive impairment remains prevalent.
We have previously shown that 10% of effectively treated patients had detectable levels of HIV-1 RNA in CSF despite having undetectable levels in plasma, suggesting that some individuals may have a continuous low grade CNS infection.
Our current research project will evaluate the occurrence of detectable CSF HIV-1 RNA longitudinally, in relation to immune activation and neuronal damage.